drugset / Trial / NCT07093476
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 3 study to assess the Efficacy and Safety of CT-L02-301 in Type 2 Diabetes Patients with Insufficient Glycemic Control with Metformin and Alogliptin Combination Therapy.
Timeline
- Start
- 2025-07-18
- Primary completion
- 2026-12
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | — | Oral |
| Comparator | Alogliptin | Unknown | — | Oral |
| Comparator | Metformin | Small molecule | — | Oral |